New Cancer Therapy Study Findings Have Been Reported by Investigators at Shandong University (Tumor-selective Activation of Toll-like Receptor 7/8 Agonist Nano-immunomodulator Generates Safe Anti-tumor Immune Responses Upon Systemic ...)

Media coverage

• Title	New Cancer Therapy Study Findings Have Been Reported by Investigators at Shandong University (Tumor-selective Activation of Toll-like Receptor 7/8 Agonist Nano-immunomodulator Generates Safe Anti-tumor Immune Responses Upon Systemic ...)
  Media name/outlet	Immunotherapy Daily
  Country/Territory	United States
  Date	27/12/22
  URL	ct.moreover.com/?a=49608508022&p=1gw&v=1&x=w3ElyJ1ZR7uu4IxDza9OQw
  Persons	Yutong Liu